Gravity Diagnostics

Executive Summary

Gravity Diagnostics is a CAP-accredited and CLIA-certified diagnostic laboratory headquartered in Covington, Kentucky, serving all 50 U.S. states. Founded in 2014, the company offers a comprehensive menu of testing services spanning toxicology, pharmacogenetics, infectious and upper respiratory diseases, blood testing, and COVID-19. Its client base ranges from small private practices to Fortune 500 companies and public health organizations, reflecting the lab’s ability to scale and adapt to diverse customer needs. By leveraging state-of-the-art technology and a rigorous quality management system, Gravity Diagnostics has positioned itself as a reliable partner in the rapidly evolving diagnostic landscape. The lab’s broad test menu and national reach provide a strong foundation for continued growth, particularly as demand for decentralized and rapid testing solutions increases. Looking ahead, Gravity Diagnostics is well positioned to capitalize on several growth opportunities. The company is likely to expand its pharmacogenetic testing portfolio, capitalizing on the growing trend toward personalized medicine. Additionally, its established infrastructure for infectious disease testing could support new assay launches in response to seasonal respiratory outbreaks or emerging pathogens. With a proven operational track record and a scalable business model, Gravity Diagnostics is poised to capture market share in the fragmented diagnostic testing industry. However, as a private company, financial transparency is limited, and execution risk remains in a competitive environment with larger players.

Upcoming Catalysts (preview)

• Q3 2026Expansion of Pharmacogenetic Testing Menu70% success
• Q4 2026New Infectious Disease Test Launch for Respiratory Panel60% success
• Q1 2027Strategic Partnership with a National Healthcare System50% success